[{"address1": "2000 Sierra Point Parkway", "address2": "Suite 400", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "415 798 8589", "website": "https://www.tempesttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.", "fullTimeEmployees": 21, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen R. Brady J.D., LLM", "age": 54, "title": "CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 894300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicholas  Maestas", "age": 44, "title": "CFO, Head of Corporate Strategy & Secretary", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 465615, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Samuel  Whiting M.D., Ph.D.", "age": 58, "title": "Executive VP, Chief Medical Officer and Head of R&D", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 671387, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lindsay  Young", "title": "Head of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.33, "open": 9.35, "dayLow": 9.35, "dayHigh": 10.0973, "regularMarketPreviousClose": 9.33, "regularMarketOpen": 9.35, "regularMarketDayLow": 9.35, "regularMarketDayHigh": 10.0973, "payoutRatio": 0.0, "beta": -2.311, "forwardPE": -7.2644925, "volume": 27169, "regularMarketVolume": 27169, "averageVolume": 136308, "averageVolume10days": 106630, "averageDailyVolume10Day": 106630, "bid": 7.24, "ask": 12.31, "bidSize": 2, "askSize": 2, "marketCap": 44512604, "fiftyTwoWeekLow": 5.356, "fiftyTwoWeekHigh": 20.67, "fiftyDayAverage": 7.5017, "twoHundredDayAverage": 9.401015, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 38895616, "profitMargins": 0.0, "floatShares": 3887228, "sharesOutstanding": 4440160, "sharesShort": 216181, "sharesShortPriorMonth": 365690, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0587, "heldPercentInsiders": 0.0011, "heldPercentInstitutions": 0.19406, "shortRatio": 2.38, "shortPercentOfFloat": 0.0587, "impliedSharesOutstanding": 4440160, "bookValue": 2.204, "priceToBook": 4.5485477, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -43099000, "trailingEps": -14.52, "forwardEps": -1.38, "lastSplitFactor": "1:13", "lastSplitDate": 1744156800, "enterpriseToEbitda": -0.903, "52WeekChange": -0.45693392, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 10.025, "recommendationKey": "none", "totalCash": 14280000, "totalCashPerShare": 3.216, "ebitda": -43091000, "totalDebt": 8663000, "quickRatio": 2.0, "currentRatio": 2.115, "debtToEquity": 88.552, "returnOnAssets": -0.81338996, "returnOnEquity": -3.22573, "freeCashflow": -21523876, "operatingCashflow": -36798000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TPST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Tempest Therapeutics, Inc.", "longName": "Tempest Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1352730600000, "postMarketChangePercent": -0.24937277, "postMarketPrice": 10.0, "postMarketChange": -0.024999619, "regularMarketChange": 0.6949997, "regularMarketDayRange": "9.35 - 10.0973", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1755906381, "regularMarketTime": 1755892800, "exchange": "NCM", "messageBoardId": "finmb_552715229", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 7.449086, "regularMarketPrice": 10.025, "cryptoTradeable": false, "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 136308, "fiftyTwoWeekLowChange": 4.6689997, "fiftyTwoWeekLowChangePercent": 0.8717326, "fiftyTwoWeekRange": "5.356 - 20.67", "fiftyTwoWeekHighChange": -10.645, "fiftyTwoWeekHighChangePercent": -0.5149976, "fiftyTwoWeekChangePercent": -45.69339, "dividendDate": 1544400000, "earningsTimestampStart": 1762977600, "earningsTimestampEnd": 1762977600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -14.52, "epsForward": -1.38, "epsCurrentYear": -12.78, "priceEpsCurrentYear": -0.7844288, "fiftyDayAverageChange": 2.5232997, "fiftyDayAverageChangePercent": 0.33636373, "twoHundredDayAverageChange": 0.62398434, "twoHundredDayAverageChangePercent": 0.066374145, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Tempest Therapeutics Inc.", "nameChangeDate": "2025-08-22", "displayName": "Tempest Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]